{"symbol": "PBYI", "companyName": "Puma Biotechnology Inc", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.pumabiotechnology.com", "description": "Puma Biotechnology Inc is a biopharmaceutical company. It is engaged in the acquisition, development and commercialization of products to enhance cancer care. Its drug candidates are PB272 (neratinib, oral), PB272 (neratinib, intravenous), and PB357.", "CEO": "Alan H. Auerbach", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}